Literature DB >> 18365227

Vestibular evoked myogenic potentials in Behcet's disease.

Seyra Erbek1, Selim S Erbek, Sema Yilmaz, Eftal Yucel, Levent N Ozluoglu.   

Abstract

The aim of this study was to investigate vestibular evoked myogenic potentials (VEMPs) and their clinical significance in Behcet's disease. Twenty-six patients with Behcet's disease and 25 healthy volunteers were evaluated for pure tone audiometry, caloric response, and VEMPs. Sensorineural hearing loss was found in 53.8% of patients with Behcet's disease, which was significantly higher than controls. Four patients had canal paresis, but no controls; this difference was not significant. Although VEMP recordings were elicited in all study subjects, mean p13 and n23 latencies were prolonged in Behcet's patients compared with controls. Seven patients had delayed VEMP responses. There were no correlations regarding p13 values and age, duration or activity of disease, vertigo, or sensorineural hearing loss. The results of this preliminary study suggest an association between delayed VEMP responses and Behcet's disease. Further research with large samples is needed to confirm that VEMP testing is useful to diagnose and follow vestibular dysfunction in Behcet's disease.

Entities:  

Mesh:

Year:  2008        PMID: 18365227     DOI: 10.1007/s00405-008-0650-8

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  19 in total

Review 1.  Current status of electronystagmography testing.

Authors:  S A Bhansali; V Honrubia
Journal:  Otolaryngol Head Neck Surg       Date:  1999-03       Impact factor: 3.497

2.  Audio-vestibular evaluation in patients with Behçet's syndrome.

Authors:  C Evereklioglu; Y Cokkeser; S Doganay; H Er; A Kizilay
Journal:  J Laryngol Otol       Date:  2001-09       Impact factor: 1.469

Review 3.  Vestibular evoked myogenic potentials: history and overview.

Authors:  Guangwei Zhou; L Clarke Cox
Journal:  Am J Audiol       Date:  2004-12       Impact factor: 1.493

Review 4.  Standard and novel therapeutic approaches to Behçet's disease.

Authors:  Ahmet Gul
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 5.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

6.  Diagnostic value of prolonged latencies in the vestibular evoked myogenic potential.

Authors:  T Murofushi; K Shimizu; H Takegoshi; P W Cheng
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2001-09

7.  Hearing loss in Behçet's disease.

Authors:  L Soylu; B Aydoğan; M Soylu; C Ozsahinoğlu
Journal:  Ann Otol Rhinol Laryngol       Date:  1995-11       Impact factor: 1.547

8.  Inner ear involvement in Behçet's disease.

Authors:  I Brama; M Fainaru
Journal:  Arch Otolaryngol       Date:  1980-04

9.  Abnormal electronystagmography in rheumatoid arthritis.

Authors:  Sema Yilmaz; Seyra Erbek; Selim S Erbek; Nuri Ozgirgin; Eftal Yucel
Journal:  Auris Nasus Larynx       Date:  2006-12-08       Impact factor: 1.863

10.  Vestibular evoked myogenic potentials in benign paroxysmal positional vertigo and Meniere's disease.

Authors:  Güzin Akkuzu; Babur Akkuzu; Levent N Ozluoglu
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-02-16       Impact factor: 2.503

View more
  2 in total

1.  Audiological and vestibular measurements in Behçet's disease.

Authors:  Ozlem Ertugrul; Ahmet Mutlu; Ilkin Zindanci; Osman Halit Cam; Levent Ozluoglu
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-03-30       Impact factor: 2.503

2.  Auditory involvement in Behcet's disease: relationship with demographic, clinical, and therapeutic characteristics.

Authors:  Jurgen Sota; Antonio Vitale; Ida Orlando; Giuseppe Lopalco; Rossella Franceschini; Claudia Fabiani; Mauro Galeazzi; Giacomo Emmi; Stefano Gentileschi; Florenzo Iannone; Bruno Frediani; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2016-07-31       Impact factor: 2.980

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.